相关实验视频

Updated: Jan 17, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

同基因特异性RNAi疗法纠正了Schuurs-Hoeijmakers综合征中的细胞外矩阵缺陷

Lylia Mekzine¹, Natalia Pinzón², Kamel Mamchaoui¹

¹Sorbonne Université, INSERM, Centre de Recherche en Myologie, Institut de Myologie, 75013 Paris, France.

American journal of human genetics

|September 19, 2025

概括

研究人员开发了一种针对Schuurs-Hoeijmakers综合征 (SHMS) 的等位基因特异性RNA干扰疗法. 这种方法使突变的PACS1基因沉默,纠正细胞外矩阵缺陷,并为这种罕见的神经发育障碍提供潜在的治疗方法.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
治疗方法治疗方法

背景情况:

舒尔斯-霍伊迈克尔综合征 (SHMS) 是一种罕见的神经发育障碍,由PACS1基因的特定突变引起.
目前对SHMS的治疗方法是不可用的,需要新的治疗策略.

研究的目的:

开发一种异位基因特异性RNA干扰 (siRNA) 策略,以使SHMS中突变的PACS1异位基因沉默.
研究SHMS背后的病理生理机制,专注于细胞外矩阵失调.

主要方法:

从SHMS患者的纤维细胞体内查,以确定有效的siRNAs.
转录组分析以评估SHMS纤维细胞中的基因表达变化.
对所选 siRNA 对 COL8A1 表达和细胞外矩阵组织的治疗效果的评估.

主要成果:

鉴定了siRNA序列,这些序列特别沉默了突变的PACS1转录,同时保留了野生类型.
揭示了SHMS纤维细胞中细胞外矩阵组织的调节失调,包括COL8A1表达升高.
证明基因特异性siRNA治疗纠正了患者衍生细胞中的COL8A1失调.

结论:

作为SHMS的治疗方法,基因特异性RNA干扰的概念验证.
已确立的细胞外矩阵功能障碍作为SHMS的关键病理生理机制.
验证的等位基因特异性沉默作为对主要遗传性疾病的安全和有效的治疗策略.

关键词:

在 COL8A1 中使用.这就是PACS1的意义.舒尔斯 - 霍伊迈克尔综合征特定于等位基因的沉默疗法细胞外矩阵是细胞外矩阵.患者衍生的纤维细胞.

更多相关视频

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

相关概念视频

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...